Category: #COVID-19

Featured image for “Long COVID and its relationship to MS”

Long COVID and its relationship to MS

If intermittent EBV reactivation drives long COVID and MS, it should respond to EBV antiviral strategies. I am aware that…

Stuart Schlossman

Featured image for “COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review”

COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review

Published: 23 October 2024 Rahul H. Dave, Heidi Crayton, Augusto Miravalle, Ming-Hui Tai, Kerri Wyse, Katherine Houghton, Abby Hitchens & Regina Berkovich DOWNLOAD THE PDF ABSTRACTIntroductionReal-world data are required to…

Stuart Schlossman

Breakthrough COVID-19 Vaccine Injury Study Links mRNA Vaccines to Triggering Autoimmune Diseases

TrialSite Staff Staff at TrialSite | Quality Journalism Mar. 4, 2023, 2:00 p.m. Physician-investigators at King Fahad University Hospital in…

Stuart Schlossman

COVID-19 Could Trigger MS Via ‘Molecular Mimicry,’ Study Shows

  By Marisa Wexler, MS on 01/10/2023 A protein in the virus that causes COVID-19 is structurally similar to several…

Stuart Schlossman

At-Home OTC COVID-19 Diagnostic Tests / Expiration Date information

 December 14, 2022 General Information About At-Home OTC COVID-19 Diagnostic Tests This page has information about at-home over-the-counter (OTC) COVID-19…

Stuart Schlossman

EVUSHELD is no longer effective against newer Omicron subvariants

 Article provided by: Cherie C Binns RN MSCN As SARS-CoV-2, the virus that causes COVID-19, continues to evolve, monoclonal antibodies are no…

Stuart Schlossman

Video: MS Views NOW – Dietary Approaches for MS, Covid updates for those with Multiple Sclerosis, medication information and more

  Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…

Stuart Schlossman

Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies

 ORIGINAL RESEARCH article –  Front. Immunol., 05 August 2022    https://doi.org/10.3389/fimmu.2022.926318   — Sec. Vaccines and Molecular Therapeutics –   —————————————– https://www.frontiersin.org/journals/immunology…

Stuart Schlossman

Should you get a Tdap vaccine with MS?

  Most people with MS use disease-modifying therapies (DMTs). These are medications that dampen the effects of your immune system, helping…

Stuart Schlossman

DMT for Multiple Sclerosis Tied to Lower Risk for In-Hospital COVID-19 Mortality

 Mortality among patients with multiple sclerosis (MS) hospitalized for COVID-19 was lower among patients taking disease-modifying therapy (DMT), according to…

Stuart Schlossman

Categories

Latest Blog Posts